PMC:7696151 / 1037-1297
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 28 | 37-40 | Chemical | denotes | HCQ | MESH:D006886 |
| 29 | 196-203 | Chemical | denotes | glucose | MESH:D005947 |
| 30 | 208-213 | Chemical | denotes | lipid | MESH:D008055 |
| 38 | 86-105 | Disease | denotes | autoimmune diseases | MESH:D001327 |
| 39 | 114-134 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 40 | 136-155 | Disease | denotes | lupus erythematosus | MESH:D008180 |
| 41 | 161-177 | Disease | denotes | Sjögren syndrome | MESH:D012859 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 86-105 | Phenotype | denotes | autoimmune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
| T2 | 114-134 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 24-178 | Sentence | denotes | By contrast, HCQ arises as a first-line treatment in managing autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and Sjögren syndrome. |